7MQ-19374-09865
3 vaccinations
11 coded responses
38 check-ins
11 free-text entries
7 call cases
- Sex
- Male
- Age at first dose
- 61-65
- ZIP prefix
- 276 / NC
- Registered
- 2021-03-20
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-20
Registered in v-safe
-
2021-03-20
Dose 1 — Janssen/Johnson & Johnson
-
2021-03-20
Health check-in — day 0, dose 1Feeling: Good · Joint pains, Fatigue or tiredness, NauseaAdult check-in
-
2021-03-21
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-22
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
- 2021-03-23
- 2021-03-24
-
2021-03-25
Survey response — days 1–6 daily, dose 1MedDRA: Vision blurred — Feeling: Good · Be unable to workFree text: Blurred vision in both eyesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-26
- 2021-03-27
- 2021-04-03
- 2021-04-12
-
2021-04-17
Survey response — day 28, single doseMedDRA: Anxiety, Asthenia, Depression, Fatigue — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Increased anxiety and depression, weakness, fatigueMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-17
Report sent to call center — day 28, single doseBe unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-04-24
Survey response — day 35, single doseMedDRA: Arthritis, Disturbance in attention, Fatigue — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Fatigue, trouble concentrating, need to sleep, increased sense of pain from arthritis.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-24
Report sent to call center — day 35, single doseBe unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-05-01
Survey response — day 42, single doseMedDRA: Anxiety, Depression, Dizziness, Lethargy — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Lethargy, depression, sadness, anxiety, dizzinessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-01
Report sent to call center — day 42, single doseBe unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-05-25
- 2021-06-19
-
2021-09-18
Survey response — 6 months, dose 1MedDRA: Fatigue, Gastrointestinal disorder — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Stomach problems, fatigueMedDRA releases: 2024-11 · check-in free text available
-
2021-10-26
Dose 2 — Janssen/Johnson & Johnson
-
2021-11-01
Health check-in — days 1–6 daily, dose 2Feeling: Good · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-11-02
Health check-in — day 7, dose 2Feeling: Good · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-11-09
- 2021-11-16
- 2021-11-23
- 2021-11-30
- 2021-12-07
- 2022-01-25
-
2022-04-26
Dose 3 — ModernaCo-administered: Shingles
-
2022-04-28
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
-
2022-04-28
Survey response — 6 months, dose 2MedDRA: Asthenia, Injection site pain — Feeling: FairFree text: Sore arm at the injection site, feeling drained.MedDRA releases: 2024-11 · check-in free text available
-
2022-04-29
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2022-04-30
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Diarrhea · Be unable to do your normal daily activitiesAdult check-in
-
2022-05-01
Survey response — days 1–6 daily, dose 3MedDRA: SARS-CoV-2 test positive — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: I tested positive for COVID-19MedDRA releases: 2024-11 · check-in free text available
-
2022-05-01
Report sent to call center — days 1–6 daily, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-05-02
Survey response — days 1–6 daily, dose 3MedDRA: Ageusia, Anosmia — Feeling: Poor · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea, Abdominal pain · Be unable to do your normal daily activitiesFree text: Loss of taste and smellMedDRA releases: 2024-11 · check-in free text available
-
2022-05-02
Call successfulCompleted over the phone
-
2022-05-03
Survey response — day 7, dose 3MedDRA: Brain fog, Productive cough — Feeling: Poor · Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Brain fog, starting to cough with clear phlegmMedDRA releases: 2024-11 · check-in free text available
-
2022-05-03
Report sent to call center — day 7, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-05-04
Call successfulReported to VAERS voluntarily prior to GDIT contact
- 2022-05-12
- 2022-05-17
-
2022-05-24
Survey response — day 28, dose 3MedDRA: Anxiety, Brain fog, Decreased appetite, Diarrhoea, Insomnia, Migraine, Nausea, Unevaluable event, Vertigo, Vomiting — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Symptoms: Migraine headaches, nausea and vomiting, vertigo, loss of appetite, diarrhea, inability to sleep, intense anxiety, and feeling I'm losing my mind · Healthcare visit (other): lab blood workMedDRA releases: 2024-11 · check-in free text available
-
2022-05-24
Report sent to call center — day 28, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-05-25
- 2022-05-31
- 2022-06-01
-
2022-06-03
Call successfulCompleted over the phone
-
2022-06-07
Survey response — day 42, dose 3MedDRA: Diarrhoea, Nausea, Tinnitus, Vertigo — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Severe vertigo and loud tinnitus, diarrhea, and nauseaMedDRA releases: 2024-11 · check-in free text available
-
2022-06-07
Report sent to call center — day 42, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-06-09
- 2022-06-09
- 2022-06-09
- 2022-06-09
- 2022-06-09
- 2022-06-09
- 2022-06-09
- 2022-06-14
- 2022-06-14
- 2022-06-14
- 2022-06-14
- 2022-06-14
- 2022-06-14
- 2022-06-14
- 2022-07-26
- 2022-10-25
- 2023-04-26
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-20 | Janssen/Johnson & Johnson | |
| 2 | 2021-10-26 | Janssen/Johnson & Johnson | No |
| 3 | 2022-04-26 | Moderna | Shingles |
Call center
7 call center cases
6 successful · 1 unsuccessful
VAERS report filed, before or during a call: 3
2 waits over 3 months for a first call
Free text
Release 6 — days 1–6 daily, dose 1
Systemic reaction (other): Blurred vision in both eyes
Release 7 — day 28, single dose
Symptoms: Increased anxiety and depression, weakness, fatigue
Release 7 — day 35, single dose
Symptoms: Fatigue, trouble concentrating, need to sleep, increased sense of pain from arthritis.
Release 8 — day 42, single dose
Symptoms: Lethargy, depression, sadness, anxiety, dizziness
Release 9 — 6 months, dose 1
Symptoms: Stomach problems, fatigue
Release 11 — 6 months, dose 2
Symptoms: Sore arm at the injection site, feeling drained.
Release 11 — days 1–6 daily, dose 3
Systemic reaction (other): I tested positive for COVID-19
Systemic reaction (other): Loss of taste and smell
Release 11 — day 7, dose 3
Systemic reaction (other): Brain fog, starting to cough with clear phlegm
Release 11 — day 28, dose 3
Symptoms: Migraine headaches, nausea and vomiting, vertigo, loss of appetite, diarrhea, inability to sleep, intense anxiety, and feeling I'm losing my mind
Healthcare visit (other): lab blood work
Release 11 — day 42, dose 3
Symptoms: Severe vertigo and loud tinnitus, diarrhea, and nausea
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Unevaluable event | · | · | ✓ |
| SD | Anxiety | ✓ | ✓ | ✓ |
| SD | Arthritis | ✓ | ✓ | ✓ |
| SD | Asthenia | ✓ | ✓ | ✓ |
| SD | Brain fog | · | · | ✓ |
| SD | Decreased appetite | · | · | ✓ |
| SD | Depression | ✓ | ✓ | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Disturbance in attention | ✓ | ✓ | ✓ |
| SD | Dizziness | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Gastrointestinal disorder | · | · | ✓ |
| SD | Injection site pain | · | · | ✓ |
| SD | Insomnia | · | · | ✓ |
| SD | Lethargy | ✓ | ✓ | ✓ |
| SD | Migraine | · | · | ✓ |
| SD | Nausea | · | · | ✓ |
| SD | Tinnitus | · | · | ✓ |
| SD | Vertigo | · | · | ✓ |
| SD | Vomiting | · | · | ✓ |
| SRO | Ageusia | · | · | ✓ |
| SRO | Anosmia | · | · | ✓ |
| SRO | Brain fog | · | · | ✓ |
| SRO | Productive cough | · | · | ✓ |
| SRO | SARS-CoV-2 test positive | · | · | ✓ |
| SRO | Vision blurred | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release